Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

BACKGROUND: The first‐line treatment for squamous cell lung cancer (SCC) has not necessarily been established; however, our previous exploratory study suggested that the combination of nedaplatin and amrubicin would be a promising treatment approach for patients with SCC. Therefore, a phase II study...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Hirokazu, Yamaguchi, Hiroyuki, Dotsu, Yosuke, Shimada, Midori, Gyotoku, Hiroshi, Senju, Hiroaki, Takemoto, Shinnosuke, Kitazaki, Takeshi, Fukuda, Masaaki, Ogawara, Daiki, Soda, Hiroshi, Nakatomi, Katsumi, Sugasaki, Nanae, Kinoshita, Akitoshi, Nagashima, Seiji, Ikeda, Takaya, Nakamura, Yoichi, Sakamoto, Noriho, Obase, Yasushi, Fukuda, Minoru, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718021/
https://www.ncbi.nlm.nih.gov/pubmed/31309738
http://dx.doi.org/10.1111/1759-7714.13134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718021/
https://www.ncbi.nlm.nih.gov/pubmed/31309738
http://dx.doi.org/10.1111/1759-7714.13134

Ejemplares similares